Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis

Summary:

We describe a new method for the detection of different types of pathological autoantibodies against TSH receptor (TSHR) in Graves' patients sera by luminescent immunoprecipitation analysis. For this purpose three different chimeras composed of human TSHR and rat luteotropin/choriogonadotropin receptor (LH-CGR) were constructed, as was described previously (Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn LD. 1997 Thyroid 7: 867-877). They were used in the immunoprecipitation reactions: (i) the wild type TSHR (for the detection of total TSHR autoantibodies), (ii) TSHR/LH-CGR chimera wherein TSHR amino acid residues 8-165 (epitopes for thyroid stimulating antibodies) are replaced by comparable LH-CGR residues, (iii) TSHR/LH-CGR chimera wherein TSHR amino acids 261-370 (epitopes for thyroid blocking antibodies) are replaced by comparable LH-CGR residues, and (iv) TSHR/LH-CGR chimera wherein TSHR amino acids 8-165 and 261-370 are replaced by comparable LH-CGR residues (for the detection of neutral TSHR autoantibodies). DNA encoding the N-terminal 725 (of 764) amino acids of wild type TSHR (or TSHR/LH-CGR chimera) was fused to the cDNA for the 550-amino acid firefly luciferase. The hybrid proteins were produced in HeLa cells using recombinant vaccinia viruses. All fusion proteins retained the enzymatic activity of firefly luciferase and TSHR-LUC interacted with TSH with the same affinity as wild type receptor. The luciferase tagged TSHR and TSHR/LH-CGR chimeras were used for the detection of different types of TSHR autoantibodies (i.e. total, neutral, thyroid stimulating and thyroid blocking) in 63 Graves' disease and 62 normal sera by immunoprecipitation analysis. The data demonstrated positive correlation between results of immunoprecipitation assay and results obtained using cAMP bioassay or assay for TSH binding inhibitory immunoglobulins in test sera.

Key words:

TSH receptor - autoantibodies - Graves' disease - immunoprecipitation

References

• 1 Costagliola S, Morgenthaler N G, Hoermann R, Bodenhoop K, Struck J, Freitag R, Poertl S, Weglöhner W, Hollidt J M, Quadbeck B, Dumont J E, Schumm-Draeger P M, Bergmann A, Mann K, Vassart G, Usadel K-H. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.  J Clin Endocrinol Metab. 84 90-97 1999; 
• 2 Evans C, Morgenthaler N G, Lee S, Llewellyn D H, Clifton-Bligh R, John R, Lazarus J H, Chatterjee V KK, Ludgate M. Development of a luminescent bioassay for thyroid stimulating antibodies.  J Clin Endocrinol Metab. 84 374-377 1999; 
• 3 Grasso Y Z, Kim M R, Falman C, Kohn L D, Tahara K, Gupta M K. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.  Thyroid. 9 531-537 1999; 
• 4 Kim W B, Cho B Y, Park H Y, Lee H K, Kohn L D, Tahara K, Koh C S. Epitopes for thyroid stimulating antibodies in Graves' sera: A possible link of heterogeneity to differences in response to antithyroid drug treatment.  J Clin Endocrinol Metab. 81 1758-1767 1996; 
• 5 Kim W B, Chung H K, Lee H K, Kohn L D, Cho B Y. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: Therapeutic implications.  J Clin Endocrinol Metab. 82 1953-1959 1997; 
• 6 Kohn L D, Shimura H, Shimura Y, Hidaka G C, Napolitano G, Ohmor M, Laglia G, Saji M. The thyrotropin receptor.  Vitam Horm. 50 287-384 1995; 
• 7 Metzger C, Michel D, Lüske A, Schlicht H J, Mertens T. Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus.  J Virol. 68 8423-8427 1994; 
• 8 Minich W B, Behr M, Loos U. Expression of a functional tagged human thyrotropin receptor in HeLa cells using recombinant vaccinia virus.  Exp Clin Endocrinol Diabetes. 105 282-290 1997; 
• 9 Minich W B, Weymayer J D, Loos U. Expression of a biotinylated human thyrotropin receptor in HeLa cells using recombinant vaccinia virus and its application for the detection of Graves' autoantibodies.  Thyroid. 8 3-7 1998; 
• 10 Minich W B, Loos U. Isolation of radiochemically pure ¹²⁵I-labeled human thyrotropin receptor and its use for the detection of pathological autoantibodies in Graves' patients' sera.  J Endocrinol. 160 239-245 1999; 
• 11 Minich W B, Weymayer J D, Loos U. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with ¹²⁵I-neutravidin.  Exp Clin Endocrinol Diabetes. 107 555-560 1999; 
• 12 Nagayama Y, Wadsworth H L, Russo D, Chasenbalk G D, Rapoport B. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.  J Clin Invest. 88 336-340 1991; 
• 13 Paschke R, Ludgate M. The thyrotropin receptor in thyroid diseases.  N Engl J Med. 337 1675-1681 1997; 
• 14 Rapoport B, Chasenbalk G D, Jaume J C, McLachlam S M. The thyrotropin (TSH)- hormone receptor: interaction with TSH and autoantibodies.  Endocrinol Rev. 19 673-716 1998; 
• 15 Refetoff S, Sunthornthepvarakul T, Gottschalk M E, Hayashi Y. Resistance to thyrotropin and other abnormalities of the thyrotropin receptor.  Recent Prog Horm Res. 51 97-122 1996; 
• 16 Shewring G, Rees Smith B. An improved radioreceptor assay for TSH receptor antibodies.  Clin Endocrinol. 17 409-414 1982; 
• 17 Tahara K, Ban K, Minegishi T, Kohn L D. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.  Biochem Biophys Res Commun. 179 70-77 1991; 
• 18 Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn L D. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.  Thyroid. 7 867-877 1997; 
• 19 Tonacchera M, Van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont J E, Vassart G. TSH receptor and disease.  Clin Endocrinol. 44 621-633 1996; 
• 20 Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.  Eur J Endocrinol. 134 97-103 1996; 
• 21 Vlase H, Nakashima M, Graves P N, Tomer Y, Morris J C, Davis T F. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading.  Endocrinology. 136 4415-4423 1995; 
• 22 Wallaschofski H, Paschke R. Detection of thyroid stimulating (TSAB)- and thyrotropin stimulating blocking (TSBAB) antibodies with CHO cell lines expressing different TSH-receptor numbers.  Clin Endocrinol. 50 365-372 1999;